A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons

Value Health. 2023 Nov;26(11):1665-1674. doi: 10.1016/j.jval.2023.07.001. Epub 2023 Jul 17.

Abstract

Objectives: We present an empirical comparison of relative-efficacy estimate(s) from matching-adjusted indirect comparisons (MAICs) with estimates from corresponding standard anchored indirect treatment comparisons.

Methods: A total of 80 comparisons were identified from 17 publications through a systematic rapid review. A standardized metric that used reported relative treatment efficacy estimates and their associated uncertainty was used to compare the methods across different treatment indications and outcome measures.

Results: On aggregate, MAICs presented for connected networks tended to report a more favorable relative-efficacy estimate for the treatment for which individual-level patient data were available relative to the reported indirect treatment comparison estimate.

Conclusions: Although we recognize the importance of MAIC and other population adjustment methods in certain situations, we recommend that results from these analyses are interpreted with caution. Researchers and analysts should carefully consider if MAICs are appropriate where presented and whether MAICs would have added value where omitted.

Keywords: indirect treatment comparisons; matching-adjusted indirect comparison; network meta analysis; population adjusted indirect comparisons; relative efficacy; treatment efficacy.

Publication types

  • Review

MeSH terms

  • Humans
  • Outcome Assessment, Health Care* / methods
  • Treatment Outcome